HIVers with normal or even low cholesterol levels still could benefit from taking the lipid-lowering medication like Crestor (rosuvastatin), according to a study in The New England Journal of Medicine. The research, conducted among HIV-negative adults but believed to apply similarly to HIVers, has shown that the medication lowers levels of C-reactive protein in the body, a compound linked with inflammation, which boosts cardiovascular risks.
Benefits of Rosuvastatin Treatment After 12 Months
>37% reduction in C-reactive protein levels
>50% reduction in LDL or 'bad' cholesterol
Benefits of Rosuvastatin Treatment After Nearly Two Years
>65% reduction in nonfatal heart attacks
>48% reduction in nonfatal strokes
>47% reduction in the risk for heart attacks, strokes, or death due to any cardiovascular event
>20% reduction in risk of death from any cause
